Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma

Published:2019-03 Issue:3 Volume:14 Page:482-493
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Qu Yang,Emoto Katsura,Eguchi Takashi,Aly Rania G.,Zheng Hua,Chaft Jamie E.,Tan Kay See,Jones David R.,Kris Mark G.,Adusumilli Prasad S.,Travis William D.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference39 articles.

1. Pathological response after neoadjuvant chemotherapy in resectable non–small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint;Hellmann;Lancet Oncol,2014

2. Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non–small-cell lung cancers;Chaft;J Thorac Oncol,2013

3. Grading of tumor regression in non–small cell lung cancer: morphology and prognosis;Junker;Chest,2001

4. Tumour regression in non–small-cell lung cancer following neoadjuvant therapy;Junker;Histological assessment. J Cancer Res Clin Oncol,1997

5. Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy;Pataer;J Thorac Oncol,2012

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New vision of HookEfficientNet deep neural network: Intelligent histopathological recognition system of non-small cell lung cancer;Computers in Biology and Medicine;2024-08

2. Immune checkpoint inhibition in early-stage non-small cell lung cancer;Lung Cancer;2024-07

3. Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non‐small cell lung cancer in real‐world practice;The Clinical Respiratory Journal;2024-05

4. Neoadjuvante Immuntherapie bei Kopf-Hals- Plattenepithelkarzinomen;Laryngo-Rhino-Otologie;2024-05

5. Pathology of Surgically Resected Lung Cancers Following Neoadjuvant Therapy;Advances in Anatomic Pathology;2024-04-09